news, journals and articles from all over the world.
Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)—prescription medications sold under popular drug names like Ozempic and Wegovy—in the United States.
Cedars-Sinai는 U.S. News & World Report의 “2024~25년 최고의 병원” 순위에서 9년 연속 명예 목록 에 선정되었습니다.
Cedars-Sinai 连续第九年荣登《美国新闻与世界报道》(U.S. News & World Report)“2024-2025 年度最佳医院”荣誉榜。
Cedars-Sinai ha sido incluido en la Lista de Honor por noveno año consecutivo en la clasificación “Mejores hospitales 2024-25” por el U.S. News & World Report.
Cedars-Sinai has been named to the Honor Roll for the ninth consecutive year in U.S. News & World Report’s “Best Hospitals 2024-25” rankings.
Inequities in pain medication treatment received postpartum, after giving birth, were found in a Cedars-Sinai study of 18,000 women. The disparities were observed even among patients reporting the highest pain levels.
After a cold and rainy winter, it’s refreshing to plan summertime outdoor activities or a day at the beach soaking up the sun. But it’s important to remember that too much sun exposure can be harmful.
A team of investigators in Cedars-Sinai’s Department of Computational Biomedicine is spotlighting the importance of diversity in science, technology, engineering and math (STEM) education and artificial intelligence (AI) research.
Lali Medina-Kauwe, PhD, a nationally regarded expert in molecular engineering and nanoparticle cancer research, has been named associate dean of PhD programs and director of the PhD program in Biomedical and Translational Sciences at Cedars-Sinai.
Es un auxiliar médico de un hospital de la Marina de los EE. UU. que ha brindado atención médica a las tropas en la clínica y a las tropas recién salidas del campo de combate.
Clive Svendsen, PhD, executive director of the Board of Governors Regenerative Medicine Institute and professor of Medicine and Biomedical Sciences at Cedars-Sinai, is developing new treatments and models for amyotrophic lateral sclerosis (ALS) using stem cells.
Cedars-Sinai has once again earned national recognition as an LGBTQ+ Healthcare Equality Leader.
How do you know you’re having a stroke? Know the symptoms, says Shlee S. Song, MD, director of the Comprehensive Stroke Center and the Telestroke Program at Cedars-Sinai.
Cedars-Sinai digestive and liver diseases physicians and scientists will share their latest research at the annual Digestive Disease Week meeting, that takes place May 18-21, in Washington, D.C.
Cedars-Sinai experts in pulmonology, critical care medicine and lung transplant attending the May 17-22 American Thoracic Society’s (ATS) 2024 International Conference in San Diego are available to comment on scientific advances being presented throughout the conference.
Cedars-Sinai’s chief health equity officer will be available for interviews during the American Hospital Association: Accelerating Health Equity Conference, May 7-9 in Kansas City.
Cedars-Sinai investigators are using artificial intelligence (AI) to reduce serious health risks associated with pregnancy and childbirth and improve screening for some gynecological cancers.
Cedars-Sinai experts are participating in the inaugural Abu Dhabi Global Healthcare Week, May 13-15 in Abu Dhabi, United Arab Emirates, highlighting their dedication to enhancing innovation and medical advances that will have a positive impact on communities worldwide.
What can a Jewish hospital learn from World War II-era medical experiments carried out by Nazis?
A lot, as it turns out.
Paul Noble, MD, professor of Medicine at Cedars-Sinai and a leading physician-scientist in pulmonary fibrosis, recently began his one-year term as president of the highly regarded Association of American Physicians (AAP) at the group’s annual meeting in Chicago.
A recent study designed and implemented by investigators at Cedars-Sinai found that artificial intelligence (AI) can accurately evaluate cardiovascular risk during a routine chest computed tomography (CT) scan without contrast.
Cedars-Sinai investigators have discovered how brain cells responsible for working memory—the type required to remember a phone number long enough to dial it—coordinate intentional focus and short-term storage of information.
Every day, scientists across Cedars-Sinai’s vast research and clinical enterprise are focused on developing medical discoveries and breakthroughs to improve health outcomes.
Cedars-Sinai está ampliando la atención médica virtual para niños e hispanohablantes en California a través de su aplicación móvil Cedars-Sinai Connect, una opción en línea de rápido crecimiento que permite a los pacientes acceder rápidamente a los mejores profesionales sanitarios para la atención aguda, crónica y preventiva.
Cedars-Sinai has joined a White House initiative aimed at ensuring healthcare providers and companies use artificial intelligence (AI) ethically and responsibly. Together with the U.S. Department of Health and Human Services, the AI effort—announced in late 2023—is a consortium involving nearly 40 health systems and insurers.
Curtis L. Cetrulo Jr., MD, vice chair of Research in the Department of Surgery and director of the Division of Plastic Surgery, has been selected as the General William and Willa Dean Lyon Family Chair in Reconstructive and Plastic Surgery.
New research from Cedars-Sinai suggests people who are scheduled for certain medical procedures should stop taking popular weight loss drugs in the days or weeks prior to avoid complications.
It is one of the most common and painful disorders, affecting more than 6 million women in the United States. Endometriosis is often difficult to diagnose and effectively treat. But Cedars-Sinai experts find patients can now benefit from minimally invasive procedures, medications and integrative medicine.
From artificial intelligence (AI) and data integration to natural language processing and statistics, the Cedars-Sinai Department of Computational Biomedicine is utilizing the latest technological advances to find solutions to some of the most complex healthcare issues.
Investigators at Cedars-Sinai have identified risk factors that make inflammatory bowel disease (IBD) patients susceptible to developing serious conditions in other parts of their bodies.
Laurence Katznelson, MD, a national leader in graduate medical education and a distinguished physician-scientist in endocrinology and metabolism, will join Cedars-Sinai as vice dean of Medical Education on May 1.
Cedars-Sinai physicians in the Department of Medicine have created a taxonomy—a classification system including comprehensive, standardized terminology—for the rapidly evolving field of medical extended reality (MXR).
Imagine a world in which the digital watch on your wrist tracks not only your step count, but also your blood sugar, heart rate, blood pressure and respiration.
Cedars-Sinai and BlackDoctor.org will host a virtual community conversation to help inspire Black doctors considering a career in medicine, research and healthcare.
Cedars-Sinai will host 10 Dutch health technology startups in Los Angeles to share best practices on bringing innovative ideas and products to the U.S. market.
The Continuing Medical Education program at Cedars-Sinai has earned Joint Accreditation with Commendation, enhancing continuing education opportunities for healthcare professionals and signifying that Cedars-Sinai upholds the highest standards in providing relevant, effective, practice-based education.
Investigators from Cedars-Sinai; the University of California, San Francisco (UCSF); Harvard University; and the Weizmann Institute of Science in Israel conducted a study to determine where individual nutrients are absorbed in the small intestine. For the first time, they identified the molecular markers that define five distinct intestinal regions.
High-risk pregnancy specialists from Cedars-Sinai will share their research findings at the Society for Maternal-Fetal Medicine 2024 Pregnancy Meeting, Feb.10-14, in National Harbor, Maryland.
Cedars-Sinai clinicians and artificial intelligence experts have developed a new application that takes advantage of the unique capabilities of Apple Vision Pro to support patients’ mental health needs.
Physician-scientists from the Comprehensive Stroke Center at Cedars-Sinai will be attending the International Stroke Conference Feb. 6-9 in Phoenix and are available to discuss the latest stroke news and research.
Nicolas Musi, MD, studies a spectrum of age-related disorders that can impact a healthy lifespan.
Cedars-Sinai and Space Tango are planning their third launch of pilot-scale systems for the automated in-space production of stem cells to the International Space Station.
As the number of sexually transmitted infections (STIs) sharply rises in the U.S., new evidence suggests that a common antibiotic—doxycycline—could help prevent the spread of some bacterial infections.
It was another boo-tiful Halloween celebration at the Cedars-Sinai Neonatal Intensive Care Unit (NICU) on Thursday. Hand-sewn costumes had been specially made for the smallest babies by Cedars-Sinai volunteers and were laid out in the NICU for parents to select.
She was five days postpartum. Her first child was a perfect baby girl. What was supposed to be among the happiest times in Marisa Dominguez’s life was, instead, the scariest.
Artificial intelligence (AI) already is making a difference in healthcare by helping medical professionals interpret tests, clarify diagnoses and identify the most effective treatment approaches to a range of diseases.
Cedars-Sinai infectious disease specialists and investigators will present research and discuss clinical advances throughout IDWeek, taking place in Boston from Oct. 11-15.
Cedars-Sinai recently announced the selection of Joshua Levy, PhD, as the new director of Digital Pathology Research. Levy also will hold a joint appointment in the Department of Computational Biomedicine.
Cedars-Sinai maternal-fetal medicine leader Kimberly Gregory, MD, MPH, is the new chair of the California Pregnancy-Associated Review Committee (CA-PARC).
Cedars-Sinai has selected Curtis L. Cetrulo Jr., MD, as the new vice chair of Research in the Department of Surgery, director of the Division of Plastic Surgery and director of Vascularized Composite Allotransplantation Program Development.
English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu